Leading the Future of Scientific Innovation
Event Recap : Revvity Signals NEXUS Europe 2025
August 5, 2025 Read Blog
Mary Donlan, Ph.D.
Executive Director, Product Marketing
Event Recap : Revvity Signals NEXUS Europe 2025
August 5, 2025 Read Blog
Executive Director, Product Marketing
Explore trends, challenges, and opportunities for the future of drug discovery in a data-driven era and how AI and innovation continue to expand.
Signals One unifies and structures data to be AI-ready. Our automation allows AI and machine-learning tools analyze data so that scientists can focus on innovation.
Artificial intelligence (AI) and machine learning (ML) are revolutionizing the cybersecurity space. Learn how Revvity Signals uses AI and other techniques to protect data.
AI boosts brightfield imaging for fast, label-free cell analysis.
This article discusses how Indian CROs are driving a new era in pharmaceutical R&D, leveraging AI, data-driven insights, and digital platforms to accelerate drug discovery, boost efficiency, and enable global collaboration.
Discover how to accelerate innovation through data-driven formulation R&D workflows with Revvity Signals One.
How Signals One with AI Enhancement Empowers Researchers.
AI boosts brightfield imaging for fast, label-free cell analysis.
This article discusses how Indian CROs are driving a new era in pharmaceutical R&D, leveraging AI, data-driven insights, and digital platforms to accelerate drug discovery, boost efficiency, and enable global collaboration.
Discover six key best practices that help medical monitors detect risks early in clinical trials by leveraging data-driven insights and proactive monitoring strategies.
Discover how Revvity Signals' dedicated Customer Experience team helps clients build robust, efficient, and cost-effective research operations through expert support, innovative SaaS solutions, and a customer-first approach.
This article discusses the critical importance of centralized data management tools in improving research efficiency within the FAIR (Findable, Accessible, Interoperable, and Reusable) data landscape.
AI and integrated software capabilities are shaping the way scientists conduct research. Read how Josh Bond explains Revvity Signals' vision for the future of scientific research.
This article highlights the role of data strategies in accelerating the development of new drug modalities
This article highlights the importance of unifying and contextualizing drug discovery data to harness the full potential of advanced analytics.
This article highlights the critical role of an AI-ready data strategy in drug discovery, emphasizing that AI is only as effective as the quality of data it processes.
This article explores how AI and ML are revolutionizing drug discovery by enhancing data accessibility, automating chemical reaction recommendations, and improving cellular imaging.